Renaissance Technologies’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-129,856
| Closed | -$156K | – | 4174 |
|
|
2023
Q1 | $156K | Buy |
129,856
+17,256
| +15% | +$20.7K | ﹤0.01% | 3360 |
|
|
2022
Q4 | $184K | Buy |
112,600
+88,000
| +358% | +$144K | ﹤0.01% | 3447 |
|
|
2022
Q3 | $30K | Buy |
24,600
+10,600
| +76% | +$12.9K | ﹤0.01% | 3846 |
|
|
2022
Q2 | $14K | Sell |
14,000
-11,500
| -45% | -$11.5K | ﹤0.01% | 4147 |
|
|
2022
Q1 | $40K | Sell |
25,500
-209,978
| -89% | -$329K | ﹤0.01% | 3936 |
|
|
2021
Q4 | $327K | Buy |
235,478
+25,578
| +12% | +$35.5K | ﹤0.01% | 3301 |
|
|
2021
Q3 | $439K | Buy |
209,900
+186,900
| +813% | +$391K | ﹤0.01% | 2936 |
|
|
2021
Q2 | $64K | Buy |
+23,000
| New | +$64K | ﹤0.01% | 3383 |
|
|
2021
Q1 | – | Sell |
-174,220
| Closed | -$415K | – | 3595 |
|
|
2020
Q4 | $415K | Buy |
174,220
+161,635
| +1,284% | +$385K | ﹤0.01% | 2902 |
|
|
2020
Q3 | $21K | Buy |
+12,585
| New | +$21K | ﹤0.01% | 3322 |
|
|
2020
Q2 | – | Sell |
-41,999
| Closed | -$58K | – | 3675 |
|
|
2020
Q1 | $58K | Buy |
+41,999
| New | +$58K | ﹤0.01% | 3303 |
|
|
2019
Q4 | – | Sell |
-37,751
| Closed | -$22K | – | 3676 |
|
|
2019
Q3 | $22K | Buy |
+37,751
| New | +$22K | ﹤0.01% | 3374 |
|
|
2018
Q4 | – | Sell |
-15,800
| Closed | -$61K | – | 3535 |
|
|
2018
Q3 | $61K | Buy |
+15,800
| New | +$61K | ﹤0.01% | 3270 |
|